News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TTP LabTech Ltd. Acquires Assets In Fluorescence Lifetime Technology


1/9/2014 11:51:10 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Royston, UK (9th January 2014) – Significant improvements in assay reagents and availability of High Throughput Screen (HTS)-compatible readers has propelled fluorescence lifetime (FLT) technology to the vanguard of cost-effective screening technologies. TTP Labtech has consolidated its position in the field with today’s announcement of the purchase of assets from AssayMetrics Limited, Cardiff, UK a leading company in FLT.

The acquisition enhances TTP Labtech’s new ameon™ system equipped with real-time decay curve analysis (RT-DCA), licensed from Fluorescence Innovations Inc (Minneapolis, US). The ameon represents the next generation of FLT reader technology providing a combination of speed, precision, and data quality that can be readily exploited in HTS workflows. “The development of the ameon reader introduces an exciting new dimension to FLT technology giving researchers a step-change in sample throughput and data quality,” said Dr Greg Gillispie, President of Fluorescence Innovations. “Reception to ameon has been very positive with early feedback from beta-partners reporting superior tolerance to compound interference compared to established methodologies,” commented Dr Wayne Bowen, Chief Scientific Officer of TTP Labtech. “Increasing access to relevant instrumentation is revealing the true potential of FLT for cost critical assays to the screening community.”

For further information please visit www.ttplabtech.com/new

About TTP Labtech Limited

Based near Cambridge, UK, TTP Labtech creates, designs and manufactures robust, reliable and easy-to-use instrumentation to offer life scientists better tools and techniques, simplifying complex operations, saving time and material costs.

We provide state-of-the-art solutions developed for specific product areas including: cell-based screening (acumen®, mirrorball®); sample management (comPOUND®, arktic®), low liquid handling (mosquito® range) and the management of analytical automation (lab2lab).

TTP Labtech is owned by its employees, and our continued drive to innovate combines cutting edge science with first rate engineering, manufacturing and outstanding customer support.

www.ttplabtech.com

About Fluorescence Innovations Inc.

Fluorescence Innovations (Minneapolis, Minnesota, USA) develops life science instrumentation that exploits the company’s proprietary technology for high throughput and precise recording of fluorescence decay data. http://www.fluorescenceinnovations.com/

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES